Sean Moloughney12.18.09
Wellmune WGP, from Biothera, Eagan, MN, significantly reduced upper respiratory tract infection symptoms in marathon runners while increasing vigor and overall health, according to a study published in the December issue of the Journal of Sports Science and Medicine.
The double-blind, placebo-controlled study included 75 runners (35 men, 40 women) ages 18-53 (mean age 36 years) from the 2007 Carlsbad Marathon in California. During the four-week period following the marathon, subjects consumed Wellmune WGP.
Wellmune WGP is Generally Recognized As Safe (GRAS) by FDA. Clinical research demonstrates that Wellmune WGP activates neutrophils, the most abundant immune cell in the body, to more quickly recognize and kill foreign challenges. Previous published research shows that physical and psychological stress reduces key immune system components, weakening immune defenses and rendering individuals more susceptible to health challenges.
“The data demonstrates the ability of Wellmune WGP to naturally enhance the body’s immune system, resulting in broad protection from stress-induced health challenges,” said Shawn Talbott, PhD, research director for SupplementWatch, Inc., and the study’s principal investigator. “These health benefits aren’t limited to elite athletes; average consumers under daily stress can strengthen their immune systems with Wellmune WGP.”
“The study results provide further support for companies that are marketing or formulating foods and beverages with Wellmune WGP,” said Richard Mueller, Biothera’s CEO. “Consumers want products that deliver real health benefits, and clinical studies consistently demonstrate that Wellmune WGP is safe and efficacious.”
The physical health results demonstrated a significant decrease in upper respiratory tract infection (URTI) symptoms at two and four weeks for subjects taking 250 mg of Wellmune WGP daily. The most common URTI symptoms reported were sore throat, stuffy or runny nose and cough.
When asked how the supplement regimen was affecting their overall health, participants consuming 250 mg of Wellmune WGP daily reported 38% higher scores compared with the placebo group. In addition, the Wellmune subjects reported significantly better scores on a variety of mood states, including a 22% increase in vigor (with 500 mg of Wellmune), 48% reduction in fatigue, 38% reduction in tension and a 38% reduction in confusion.
The study employed a Profile of Mood States (POMS) questionnaire, a validated psychometric test that measures six moods states (vigor, fatigue, tension, confusion, depression and anger) using 65 adjective-based intensity scales.
“The marathoners taking Wellmune WGP experienced fewer symptoms of upper respiratory tract infections so their energy levels and general sense of wellness were higher than the placebo group,” said Dr. Talbott. “Wellmune WGP supports both physical health and a general sense of well-being.”
The double-blind, placebo-controlled study included 75 runners (35 men, 40 women) ages 18-53 (mean age 36 years) from the 2007 Carlsbad Marathon in California. During the four-week period following the marathon, subjects consumed Wellmune WGP.
Wellmune WGP is Generally Recognized As Safe (GRAS) by FDA. Clinical research demonstrates that Wellmune WGP activates neutrophils, the most abundant immune cell in the body, to more quickly recognize and kill foreign challenges. Previous published research shows that physical and psychological stress reduces key immune system components, weakening immune defenses and rendering individuals more susceptible to health challenges.
“The data demonstrates the ability of Wellmune WGP to naturally enhance the body’s immune system, resulting in broad protection from stress-induced health challenges,” said Shawn Talbott, PhD, research director for SupplementWatch, Inc., and the study’s principal investigator. “These health benefits aren’t limited to elite athletes; average consumers under daily stress can strengthen their immune systems with Wellmune WGP.”
“The study results provide further support for companies that are marketing or formulating foods and beverages with Wellmune WGP,” said Richard Mueller, Biothera’s CEO. “Consumers want products that deliver real health benefits, and clinical studies consistently demonstrate that Wellmune WGP is safe and efficacious.”
The physical health results demonstrated a significant decrease in upper respiratory tract infection (URTI) symptoms at two and four weeks for subjects taking 250 mg of Wellmune WGP daily. The most common URTI symptoms reported were sore throat, stuffy or runny nose and cough.
When asked how the supplement regimen was affecting their overall health, participants consuming 250 mg of Wellmune WGP daily reported 38% higher scores compared with the placebo group. In addition, the Wellmune subjects reported significantly better scores on a variety of mood states, including a 22% increase in vigor (with 500 mg of Wellmune), 48% reduction in fatigue, 38% reduction in tension and a 38% reduction in confusion.
The study employed a Profile of Mood States (POMS) questionnaire, a validated psychometric test that measures six moods states (vigor, fatigue, tension, confusion, depression and anger) using 65 adjective-based intensity scales.
“The marathoners taking Wellmune WGP experienced fewer symptoms of upper respiratory tract infections so their energy levels and general sense of wellness were higher than the placebo group,” said Dr. Talbott. “Wellmune WGP supports both physical health and a general sense of well-being.”
